May 14, 2024

PiVOT Makes Waves at Bio Korea 2024, Connects with Korean CRO & Pharma Leaders

Share on Facebook Share on Twitter Share on Mail

PiVOT CRO, the leading force in Philippine contract research, recently returned from a triumphant showing at Bio Korea 2024, held in the bustling heart of Seoul. The event was more than just a conference; it was a springboard for PiVOT to showcase the Philippines’ growing prowess in clinical research on the international stage.

Key Takeaways:

• Korean Connections Strengthened: PiVOT CRO engaged in high-level discussions with decision-makers from numerous Korean CROs and pharmaceutical companies, opening doors for future collaborations. Their thoughtfully crafted, Korean-translated materials were a hit, demonstrating a deep understanding of cultural nuances.

  

• Expert Delegation: The PiVOT team, including Joseph Cheng (Business Development Head), Cheng Bigay (Marketing Manager), Kelvin Cometa (Regulatory Affairs & Pharmacovigilance Sr. Associate), and Risa Takatsu (Clinical Research Associate), brought a wealth of expertise to the table.

  

• Learning at the Forefront of Innovation: The team immersed themselves in cutting-edge knowledge, participating in sessions on:

  •  Transforming Clinical Trials of the Future: Organized by KONECT (Korea’s National Enterprise for Clinical Trials) this session shed light on innovative approaches to clinical trial design and execution using Artificial Intelligence.
  • Advancements in Diabetes-Obesity Treatment: This session explored the latest developments in the treatment of diabetes and obesity, offering valuable insights for our clinical research endeavors.
  • AI & Digital Healthcare 2024: The Age of Generative AI: This session delved into the transformative potential of artificial intelligence and generative AI in healthcare, highlighting applications in drug discovery, diagnostics, and personalized medicine.
  • Global Trends in Cancer Vaccines: This session provided a comprehensive overview of the global landscape of cancer vaccines, offering valuable insights into current research and development efforts.
  • Advanced Regenerative Medicine Bio Law: This session explored the regulatory landscape and industry developments in regenerative medicine across Asia, highlighting potential opportunities for collaboration.

    

PiVOT CRO: Your Partner in Clinical Research Excellence

PiVOT is not just the largest CRO in the Philippines; it’s a driving force behind medical innovation. With a network that spans the globe and an unwavering commitment to quality, PiVOT is accelerating the development of life-saving medications.

Interested in bringing your clinical trials to the Philippines?
Contact PiVOT CRO today and discover how they can help you achieve your research goals.